| Pharmaceutical active ingredients: |
| Rivastigmine Hydrogen Tartrate |
| Available forms, composition and doses of Mylan-Rivastigmine: |
| Capsules; Oral; Rivastigmine Hydrogen Tartrate 1.5 mgCapsules; Oral; Rivastigmine Hydrogen Tartrate 3 mgCapsules; Oral; Rivastigmine Hydrogen Tartrate 4.5 mgCapsules; Oral; Rivastigmine Hydrogen Tartrate 6 mg |
| Mylan-Rivastigmine medical category: |
| Human:Neurodegenerative disease drugsParasympathomemetic (cholinergic) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N06DA03 - Rivastigmine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Mylan |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Zeemine | Rivastigmine | Psyco Remedies |
| Apo-Rivastigmine | Rivastigmine Hydrogen Tartrate | Apotex |
| Exelon | Rivastigmine Hydrogen Tartrate | Novartis; Four Star; Zuellig Pharma |
| Exelon Parche | Rivastigmine Hydrogen Tartrate | Novartis; Zuellig Pharma |
| Exelon Patch | Rivastigmine Hydrogen Tartrate | Novartis; Four Star; Zuellig Pharma |
| Novo-Rivastigmine | Rivastigmine Hydrogen Tartrate | Novopharm |
| PMS-Rivastigmine | Rivastigmine Hydrogen Tartrate | Pharmascience |
| Prometax | Rivastigmine Hydrogen Tartrate | Novartis; Bial Laboratorios; Biosintetica Laboratorios; Esteve Farma; Sigma-Tau Pharmaceuticals |
| Ratio-Rivastigmine | Rivastigmine Hydrogen Tartrate | Ratiopharm |
| Rivasmine | Rivastigmine Hydrogen Tartrate | Cipla |